T Cell News and Research

Latest T Cell News and Research

Genes account for approximately 30 percent of longevity in humans

Current research indicates that genes account for approximately 30 percent of longevity in humans which means that healthy habits play a large role in determining lifespan but good genes do help and the question now is how

23 Jun 2004

Prostate and kidney cancer can be detected in urine

Bladder cancer is the fourth most common male cancer in the Western world. There will be more than 44,6000 new cases of bladder cancer diagnosed in U.S. men this year and more than 15,600 new cases diagnosed in women As many as 25 percent of these cancers are diagnosed after the disease is advanced, leading to a poor prognosis.

23 Jun 2004

Discovery of a gene-expression signature common to distinct types of cancer

Researchers at the University of Michigan, Johns Hopkins and the Institute of Bioinformatics in India have discovered a gene-expression "signature" common to distinct types of cancer

23 Jun 2004

We want to figure out how to grow new kidneys in humans

Growing new organs to take the place of damaged or diseased ones is moving from science fiction to reality, according to researchers at Washington University School of Medicine in St. Louis.

22 Jun 2004

John Kerry will overturn the ban on federal funding of research on new stem cell lines

Democratic Presidential candidate John Kerry today pledged to lift up families and create new jobs by once again making America the world leader in science.

22 Jun 2004

New computer cluster will help understanding of how human cells and organs work

A new computer cluster funded by the University of Sheffield and located within the Royal Hallamshire Hospital, will help scientists to improve their understanding of how human cells and organs work.

22 Jun 2004

Genetically engineering viruses to carry a suicide gene into ovarian cancer cells

Genetically engineering viruses to carry a suicide gene into ovarian cancer cells could become a potent way to tackle the disease, a leading Cancer Research UK scientist reveals at a conference in Glasgow today (Tuesday).

22 Jun 2004

Key signal in mice that tells stem cells to commit to becoming fat cells

The Hopkins team discovered that adding a single protein, dubbed BMP4, induced mouse stem cells to become fat cells. A very similar signal is likely to be involved in humans, too, say the scientists.

21 Jun 2004

Cognitive decline can occur before chemotherapy treatment

In a series of studies in breast cancer patients, researchers at The University of Texas M. D. Anderson Cancer Center have confirmed the presence of “chemobrain” after chemotherapy treatment – but they also discovered that a significant portion of patients have cognitive declines even before chemotherapy.

21 Jun 2004

Paclitaxel analog kills more cancer cells than natural product

Paclitaxel, a natural compound from yew trees, is the world's best-selling anticancer drug. Several analogs are in clinical trial, with others in preclinical development. One problem that paclitaxel and all its analogs share, however, is that they are all highly complex compounds, and cannot be prepared synthetically in a commercially viable way.

21 Jun 2004

Embryonic cell implantation improves motor skills in patients with Parkinson's disease

Patients with Parkinson disease (PD) who underwent treatment involving embryonic cell implantation had better motor functioning after their procedures than PD patients who did not receive embryonic cells

21 Jun 2004

New centre of excellence to develop stem cell treatments for diabetes and diseases of the brain

New centre of excellence at the University of Cambridge to develop stem cell treatments for diabetes and diseases of the brain, including Parkinson’s disease and multiple sclerosis.

21 Jun 2004

Targeting a gene that protects cancer cells from the lethal effects of radiotherapy could help improve the impact of treatment

Targeting a gene that protects cancer cells from the lethal effects of radiotherapy could help improve the impact of treatment, a leading Cancer Research UK scientist will tell conference delegates in Glasgow this week.

21 Jun 2004

First license to begin research involving therapeutic cloning

A special licensing committee of the UK Human Fertilization & Embryology Authority (HFEA) met on June 16 in London to decide whether to grant a license to scientists at The Center for Life at Newcastle University.

20 Jun 2004

Mothers infected with HIV who breast feed risk infecting infants

After four weeks of age, infants who breast feed from mothers infected with HIV continue to be at risk for infection with HIV for as long as they breastfeed

17 Jun 2004

Harmless virus known as GBV-C slows the progression of HIV

Iowa City Veterans Affairs (VA) Medical Center and University of Iowa (UI) researchers have unlocked part of the mystery of how a harmless virus known as GBV-C slows the progression of HIV and prolongs survival for many patients.

17 Jun 2004

A natural molecule that blocks a key bacterial enzymes could lead to a new generation of antibiotics

Rutgers scientists have deciphered the complex mechanics of microcin J25 (MccJ25), a tiny, natural molecule that acts like a cork in a bottle to block a key bacterial enzyme – potentially leading to a new generation of antibiotics.

17 Jun 2004

£11.5m for new structural proteomics research

The Biotechnology and Biological Sciences Research Council (BBSRC) has announced that two new research projects will together receive nearly £11.5m under the Structural Proteomics of Rational Targets Initiative (SPORT).

17 Jun 2004

Australian researchers awarded funding for new HIV vaccines

Australian researchers at Monash University have been awarded $488,125 in development grants by the National Health and Medical Research Council (NHMRC) for projects exploring new vaccines for HIV, the development of medical diagnostic devices and the development of drugs to treat metastatic cancers.

17 Jun 2004

Xenobiotic gets patent approval for toxin detection

XDS consultant (and former XDS laboratory director) Michael Chu and President George Clark combined their research skills to develop a rapid and relatively inexpensive methodology to quantify TEQs (Toxic Equivalence -- measures of toxicity adopted by the World Health Organization) for individual toxic chemical groups.

17 Jun 2004